热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse CD8a Antibody
产品名称：
Purified anti-mouse CD8a Antibody
产品类别：
抗体
产品编号：
100701
产品应用：
100701
[价格]
规格 价格 库存
50µg ￥ 432 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF?, IHC-F - Verified
IP - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?L?volume. For immunohistochemistry on frozen tissue sections, the suggested use of this reagent is 5.0 - 10 ?g per mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  2. Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
  3. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  4. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Baja?a S, et al. 2021. Front Immunol. 11:577718. PubMed
  7. Murata A, et al. 2020. Front Immunol. 11:775. PubMed
  8. Wang C, et al. 2020. Oncoimmunology. 9:1809947. PubMed
  9. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  10. Kao C, et al. 2005. Int Immunol. 1.824305556. PubMed
  11. Krovi SH, et al. 2019. Proc Natl Acad Sci U S A. 116:22252. PubMed
  12. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  13. Thi VAD, et al. 2019. Mol Cells. 42:869. PubMed
  14. Asthagiri Arunkumar G, et al. 2019. Vaccine. 37:5567. PubMed
  15. Burrello C, et al. 2018. Front Med (Lausanne). 5:21. PubMed
  16. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  17. Boldison J, et al. 2020. Cell Mol Immunol. 17:843. PubMed
  18. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  19. Rubio‐Pati?o C et al. 2018. Cell metabolism. 27(4):828-842 . PubMed
  20. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  21. Goel S, et al. 2017. Nature. 548:471. PubMed
  22. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  23. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  24. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  25. Haque M, et al. 2021. Viruses. 13:. PubMed
  26. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  27. Tian K, et al. 2021. J Immunol Res. 2021:6297332. PubMed
  28. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  29. Hirano J, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  30. Draganov D, et al. 2021. NPJ Breast Cancer. 7:22. PubMed
  31. Rossi DC, et al. 2021. J Clin Invest. 131:. PubMed
  32. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  33. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  34. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  35. Willimsky G, et al. 2021. Elife. 10:. PubMed
  36. Tian D, et al. 2020. FASEB J. 34:3367. PubMed
  37. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  38. Zhou AC, et al. 2017. Front Immunol. 1.136111111. PubMed
  39. Ma C, et al. 2018. Science. 360:eaan5931. PubMed
  40. Kaplanov I, et al. 2019. Proc Natl Acad Sci U S A. 116:1361. PubMed
  41. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  42. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  43. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  44. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  45. Yang M, et al. 2020. Oncoimmunology. 9:1708064. PubMed
  46. Hiramatsu-Asano S, et al. 2021. Front Immunol. 11:616141. PubMed
  47. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  48. Bartsch YC, et al. 2018. Front Immunol. 1.196527778. PubMed
  49. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  50. Recino A, et al. 2019. Gene Ther. 26:40. PubMed
  51. Wang N, et al. 2021. Mol Ther Oncolytics. 20:71. PubMed
  52. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  53. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  54. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  55. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  56. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  57. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  58. Guo Y, et al. 2008. Blood. 112:480. PubMed
  59. Sharma M, et al. 2020. Nat Commun. 11:661. PubMed
  60. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  61. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  62. Yang SH, et al. 2017. Front Immunol. 8:1192. PubMed
  63. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  64. Hiratsuka S, et al. 2018. EMBO Mol Med. 10:e8643. PubMed
  65. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  66. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  67. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  68. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  69. Mori H, et al. 2015. Toxicol Pathol. 43: 883-889. PubMed
  70. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  71. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
  72. Furukawa K,et al. 2017. PLoS One. 10.1371/journal.pone.0184901. PubMed
  73. Zhao F, et al. 2018. Cancer Immunol Res. 1.263194444. PubMed
  74. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  75. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  76. Sharba S, et al. 2019. Virulence. 10:97. PubMed
  77. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  78. Dooley K, et al. 2021. Mol Ther. 29:1729. PubMed
  79. Dai Z, et al. 2021. JCI Insight. 6: . PubMed
  80. Zhong X, et al. 2020. Proc Natl Acad Sci U S A. 8563:117. PubMed
  81. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  82. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  83. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  84. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  85. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  86. Jang SC, et al. 2021. Commun Biol. 4:497. PubMed
  87. You X, et al. 2022. Front Genet. 12:790990. PubMed
  88. Sprouse ML, et al. 2018. JCI Insight. 3:e97322. PubMed
  89. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  90. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  91. Sharabi A, et al. 2019. JCI Insight. 4:e126294. PubMed
  92. Chihara N, et al. 2018. Nature. 558:454. PubMed
  93. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  94. Majer O, et al. 2019. Nature. 575:366. PubMed
  95. Gilfillan CB, et al. 2020. Eur J Immunol. 50:505. PubMed
  96. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  97. Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
  98. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  99. Kenna T, et al. 2008. Blood. 111:2091. PubMed
  100. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  101. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  102. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  103. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  104. Bajic D, et al. 2020. Mol Cancer Ther. 19:2554. PubMed
  105. Ikezoe T, et al. 2021. Biomolecules. 11:. PubMed
  106. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  107. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  108. Tan CL, et al. 2018. Immunohorizons. 0.248611111. PubMed
  109. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  110. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  111. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  112. Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
  113. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  114. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  115. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  116. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  117. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  118. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  119. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  120. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  121. Tsai MS, et al. 2021. Int J Mol Sci. 22:. PubMed
  122. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  123. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  124. Ko S, et al. 2005. J Immunol. 175:3309. PubMed
  125. Lin Z, et al. 2021. Stem Cells. 39:240. PubMed
  126. Amobi-McCloud A, et al. 2021. Front Immunol. 12:678999. PubMed
  127. Zhang Z, et al. 2020. Front Immunol. 1.844444444. PubMed
  128. Brown ZJ, et al. 2018. Cell Death Dis. 0.805555556. PubMed
  129. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  130. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  131. Dey P, et al. 2020. Cancer Discov. 10:608. PubMed
  132. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  133. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  134. Sami E, et al. 2020. Cancer Res. 80:1102. PubMed
  135. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  136. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  137. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  138. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  139. Lee B, et al. 2019. Front Immunol. 0.561805556. PubMed
  140. Kang JG, et al. 2020. PLoS Negl Trop Dis. 14:e0007813. PubMed
  141. Gorgun FM, et al. 2021. Front Oncol. 11:701968. PubMed
  142. Freed-Pastor WA, et al. 2021. Cancer Cell. :. PubMed
  143. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  144. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  145. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  146. Sutherland APR, et al. 2019. Sci Rep. 9:15302. PubMed
  147. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  148. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  149. Pittala S, et al. 2018. Neoplasia. 9:20222. PubMed
  150. Lin J, et al. 2017. Nat Commun. . 10.1038/s41467-017-01477-5. PubMed
  151. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  152. Cong L, et al. 2021. Breast Cancer Res. 23:51. PubMed
  153. Zhang N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  154. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  155. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  156. Liu H, et al. 2022. Animal Model Exp Med. 5:72. PubMed
  157. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  158. Lee YJ, et al. 2018. FASEB J. 32:4658. PubMed
  159. Atif SM, et al. 2019. JCI Insight. 4:e125494. PubMed
  160. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  161. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  162. Genton C, et al. 2006. J Immunol. 177:2285. PubMed
  163. Jordan J, et al. 2008. Infect Immun. 76:3717. PubMed
  164. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  165. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  166. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  167. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  168. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  169. Chen YQ, et al. 2019. J Immunother Cancer. 0.415277778. PubMed
  170. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
RRID
AB_312740 (BioLegend Cat. No. 100701) AB_312741 (BioLegend Cat. No. 100702)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线